Archives: Speakers

Andrew Lucchesi is an international business development and innovation professional who leads Digital Innovation & New Business at Pelliconi, one of the world’s largest producers of bottle closures, headquartered in Bologna, Italy. His current focus is on the development and go-to-market strategy for P-Code, Pelliconi’s connected packaging platform, which enables beverage brands to activate unique QR-coded closures for consumer engagement, traceability, anti-counterfeiting and sustainability communication. Andrew works with global brands to design and scale digital activation programmes starting from their packaging.

Daniel Sullivan is Bupa’s Director of Product, Proposition and Transformation for UK Insurance. Since joining Bupa, Daniel has worked on several initiatives including: Well+, Connected Care, our SME growth strategy, genomics and most recently is part of the later living (Project Owl) working group.

Daniel joined Bupa UK in 2021 from KPMG UK where we held a variety of roles, including Director of KPMG’s Marketing Centre of Expertise. Daniel’s career has focussed on marketing and proposition management in financial services, including roles at Lloyds Banking Group and Unum.

Daniel lives in Wiltshire and has a degree in Communication Studies from the University of the West of England alongside professional qualifications from the Chartered Institute of Insurance and Chartered Institute of Marketing.

• Clinical research leader with extensive experience in global clinical trial delivery across multiple therapeutic areas
• Strong background in clinical operations, study oversight, and cross‑functional collaboration
• Combines scientific expertise with expansive operational and leadership capabilities
• Actively engaged in EU Clinical Trials Regulation (EU CTR) topics, with a focus on clinical research delivery and EU competitiveness
• Trained pharmacist (MSc, PharmD) and Project Management Professional (PMP®)

Matt Confeld is Director of Clinical Research Methodology at Worldwide Clinical Trials, with over 12 years of experience in the pharmaceutical sciences. In his current role, Matt supports biotech companies by guiding their strategic regulatory, program design, and commercialization initiatives. Throughout his career, he has successfully navigated dozens of clinical-stage oncology programs from First-in-Human (FIH) trials through Phase 3. Matt’s foundational scientific expertise is rooted in clinical pharmacogenomics and the pre-clinical drug development of nanoparticles across multiple solid tumors. Matt also actively bridges the gap between the laboratory and the clinic by serving as a translational research advisor to an NIH pancreatic cancer research center.

Daren is a Vice-President in CGI’s UK Insurance business, leading a consulting team working with clients to shape digital strategy, modernise business models, and apply emerging technologies to deliver measurable outcomes. With over 30 years’ experience in the London and General Insurance markets, Daren brings deep industry expertise alongside more than a decade in InsurTech, consulting and technology delivery. He applies a pragmatic approach in the use of technology to make a difference for the business, focusing on a lean, rapid approach to transformation and the value it creates for people. Daren is passionate about approaching complex challenges differently and believes that traditional transformation does not meet the needs of modern business. He partners with senior business and technology leaders to bridge the gap between innovation and reality, to ensure solutions are focused on real value not technology hype.